StockWatch
·
Pharmaceuticals
Shareholding16 Jun 2026, 05:30 pm

Zim Labs: Promoter Dr Anwar Daud Acquires 0.15% Stake

AI Summary

Zim Laboratories Ltd has disclosed an inter-se transfer of equity shares among its promoters. Dr. Anwar Daud acquired 80,000 equity shares, representing 0.15% of the diluted share capital, from Mr. Zulfiquar Kamal. The transaction, valued at INR 107.50 per share, falls under an exemption provided by Regulation 10(1)(a)(ii) of the SEBI SAST Regulations, thus not requiring an open offer. This move adjusts the shareholding percentages between the promoters, with Dr. Daud's stake increasing slightly to 25.05% and Mr. Kamal's decreasing to 2.08%.

Key Highlights

  • Dr. Anwar Daud acquired 80,000 shares (0.15%) from promoter Mr. Zulfiquar Kamal.
  • Transaction price was INR 107.50 per share.
  • Acquisition qualifies for exemption under SEBI SAST Regulations 10(1)(a)(ii).
  • No open offer required due to inter-se promoter transfer exemption.
  • Post-transaction, Dr. Daud holds 25.05% and Mr. Kamal holds 2.08%.